98 related articles for article (PubMed ID: 18772194)
1. Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer.
Simões-Correia J; Figueiredo J; Oliveira C; van Hengel J; Seruca R; van Roy F; Suriano G
Hum Mol Genet; 2008 Nov; 17(22):3566-76. PubMed ID: 18772194
[TBL] [Abstract][Full Text] [Related]
2. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin mutations and cell motility: a genotype-phenotype correlation.
Mateus AR; Simões-Correia J; Figueiredo J; Heindl S; Alves CC; Suriano G; Luber B; Seruca R
Exp Cell Res; 2009 May; 315(8):1393-402. PubMed ID: 19268661
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the V832M E-cadherin germ-line missense mutation does not influence the affinity of alpha -catenin for the cadherin/catenin complex.
Curtis MW; Ly QP; Wheelock MJ; Johnson KR
Cell Commun Adhes; 2007; 14(2-3):45-55. PubMed ID: 17668349
[TBL] [Abstract][Full Text] [Related]
5. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion.
Suriano G; Mulholland D; de Wever O; Ferreira P; Mateus AR; Bruyneel E; Nelson CC; Mareel MM; Yokota J; Huntsman D; Seruca R
Oncogene; 2003 Aug; 22(36):5716-9. PubMed ID: 12944922
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells.
Suriano G; Oliveira MJ; Huntsman D; Mateus AR; Ferreira P; Casares F; Oliveira C; Carneiro F; Machado JC; Mareel M; Seruca R
Hum Mol Genet; 2003 Nov; 12(22):3007-16. PubMed ID: 14500541
[TBL] [Abstract][Full Text] [Related]
7. Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro.
Ferreira P; Oliveira MJ; Beraldi E; Mateus AR; Nakajima T; Gleave M; Yokota J; Carneiro F; Huntsman D; Seruca R; Suriano G
Exp Cell Res; 2005 Oct; 310(1):99-104. PubMed ID: 16112667
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
[TBL] [Abstract][Full Text] [Related]
9. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach.
Tsanou E; Peschos D; Batistatou A; Charalabopoulos A; Charalabopoulos K
Anticancer Res; 2008; 28(6A):3815-26. PubMed ID: 19189669
[TBL] [Abstract][Full Text] [Related]
10. DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo.
Simões-Correia J; Silva DI; Melo S; Figueiredo J; Caldeira J; Pinto MT; Girão H; Pereira P; Seruca R
Hum Mol Genet; 2014 Apr; 23(8):2094-105. PubMed ID: 24293545
[TBL] [Abstract][Full Text] [Related]
11. Heterotypic trans-interaction of LI- and E-cadherin and their localization in plasmalemmal microdomains.
Baumgartner W; Wendeler MW; Weth A; Koob R; Drenckhahn D; Gessner R
J Mol Biol; 2008 Apr; 378(1):44-54. PubMed ID: 18342884
[TBL] [Abstract][Full Text] [Related]
12. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
Deplazes J; Fuchs M; Rauser S; Genth H; Lengyel E; Busch R; Luber B
Hum Mol Genet; 2009 Oct; 18(19):3632-44. PubMed ID: 19584084
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
14. Systemic hyalinosis mutations in the CMG2 ectodomain leading to loss of function through retention in the endoplasmic reticulum.
Deuquet J; Abrami L; Difeo A; Ramirez MC; Martignetti JA; van der Goot FG
Hum Mutat; 2009 Apr; 30(4):583-9. PubMed ID: 19191226
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational truncation of E-cadherin and significance for tumour progression.
Masterson J; O'Dea S
Cells Tissues Organs; 2007; 185(1-3):175-9. PubMed ID: 17587823
[TBL] [Abstract][Full Text] [Related]
16. Proteasome degradation of protein C and plasmin inhibitor mutants.
Nishio M; Koyama T; Nakahara M; Egawa N; Hirosawa S
Thromb Haemost; 2008 Sep; 100(3):405-12. PubMed ID: 18766255
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.
Simões-Correia J; Figueiredo J; Lopes R; Stricher F; Oliveira C; Serrano L; Seruca R
PLoS One; 2012; 7(3):e33783. PubMed ID: 22470475
[TBL] [Abstract][Full Text] [Related]
18. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
Huygens A; Crnolatac I; Develter J; Van Cleynenbreugel B; Van der Kwast T; de Witte PA
J Urol; 2008 May; 179(5):2014-9. PubMed ID: 18355860
[TBL] [Abstract][Full Text] [Related]
19. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression.
Wang L; Li Z; Wang C; Yang Y; Sun L; Yao W; Cai X; Wu G; Zhou F; Zha X
Arch Biochem Biophys; 2009 Jan; 481(1):116-22. PubMed ID: 18983973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
